Production of novel Zr–Mg nanoceramics based on kaolinite clay with strong antibacterial activity

Abstract

Gram-negative bacteria Pseudomonas putida, Gram-positive Bacillus subtilis, and Staphylococcus aureus were utilized as test samples to evaluate the antibacterial characteristics of DD3-clay/MgO and DD3+38 wt% ZrO2-clay/MgO nanoparticles. The ceramic powders prepared by a thermal autoclave method are characterized before and after Mg addition by SEM, EDX, XRD, IR, UV–visible, and TEM in order to investigate microstructure, phase, and surface morphology. The results showed that after adding Mg, it led to the deformation of the crystal lattices of (mullite, zirconium silicate, and zirconium oxide) together with a decrease in particle size (75–103 nm) and a complete change in its shape from nanotube to nanospherical, as observed by SEM and TEM analyses. It also confirmed by UV–visible spectroscopy that the addition of Mg increases the absorbance accompanying a decrease in the energy gap of 1.91, 1.74, 1.73, and 1.43 eV corresponding to DD3, DD3Z, DD3/30 wt% Mg and DD3Z/30 wt% Mg respectively. The antibacterial mechanism is related to the size of the particles, the solvent used for powder dissolution, the nanoparticle's size when they come into touch with bacteria, and the generation of reactive oxygen species (ROS: ˙O2−, ˙OH, and H2O2). It was observed that the anti-bacterial activity is enhanced with 10 wt% and 30 wt% of Mg added to a modified ceramic powder. Also, more O2− is formed on the surface of the prepared powder, which penetrates the bacterial cell and destroys it. The nanocomposite particles showed remarkable antibacterial activity when they were dissolved in DMSO compared to methanol and chloroform as organic solvents. The aim is to enrich knowledge on the antibacterial activities of metal nanoparticles (ZrSiO4 and MgO) on three bacterial strains with different Grams due to their extensive involvement in the phenomena of contamination and infection encountered in the medical field. The synthesized nanoparticles have good antimicrobial activity against all strains tested. A maximum inhibition zone of 35 ± 0.2 mm was obtained with S. aureus, a zone of 23 ± 0.46 mm with P. putida and a zone of 27 ± 0.46 nm with B. subtilis for DD3/30 wt% Mg and an inhibition zone of 38 ± 0.93 mm, 26 ± 0.24 nm and 17 ± 0.33 nm was obtained with same strains for DD3Z/30 wt% Mg, respectively.